Estimating prevalence in single-gene kidney diseases progressing to renal failure, Kidney International, vol.58, issue.3, pp.925-943, 2000. ,
DOI : 10.1046/j.1523-1755.2000.00250.x
Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families, Acta Med. Scand, vol.328, pp.1-255, 1957. ,
Epidemiology of adult polycystic kidney disease ,
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry, Nephrology Dialysis Transplantation, vol.29, issue.suppl 4 ,
DOI : 10.1093/ndt/gfu017
PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein, Science, vol.272, issue.5266, pp.1339-1342, 1996. ,
DOI : 10.1126/science.272.5266.1339
Comparison of phenotypes of polycystic kidney disease types 1 and 2, The Lancet, vol.353, issue.9147 ,
DOI : 10.1016/S0140-6736(98)03495-3
The Position of the Polycystic Kidney Disease 1 (PKD1) Gene Mutation Correlates with the Severity of Renal Disease, Journal of the American Society of Nephrology, vol.13, issue.5, pp.1230-1237, 2002. ,
DOI : 10.1097/01.ASN.0000013300.11876.37
Genetics and Pathogenesis of Autosomal Dominant Polycystic Kidney Disease: 20 Years On, Human Mutation, vol.30, issue.12, pp.1393-1406, 2014. ,
DOI : 10.1111/cge.12383
The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains, Nature Genetics, vol.10, issue.2, pp.151-160, 1995. ,
DOI : 10.1016/0014-5793(92)80506-C
Characterization of the Exon Structure of the Polycystic Kidney Disease 2 Gene (PKD2), Genomics, vol.44, issue.1, pp.131-136, 1997. ,
DOI : 10.1006/geno.1997.4851
Autosomal dominant polycystic kidney disease, The Lancet, vol.369, issue.9569, pp.1287-1301, 2007. ,
DOI : 10.1016/S0140-6736(07)60601-1
URL : https://hal.archives-ouvertes.fr/hal-01328055
Strategies Targeting cAMP Signaling in the Treatment of Polycystic Kidney Disease, Journal of the American Society of Nephrology, vol.25, issue.1, pp.18-32, 2014. ,
DOI : 10.1681/ASN.2013040398
A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation, Nature Genetics, vol.94, issue.7 ,
DOI : 10.1074/jbc.274.40.28557
Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist, Nature Medicine, vol.9, issue.10, pp.1323-1326, 2003. ,
DOI : 10.1038/nm935
Octreotide Inhibits Hepatic Cystogenesis in a Rodent Model of Polycystic Liver Disease by Reducing Cholangiocyte Adenosine 3???,5???-Cyclic Monophosphate, Gastroenterology, vol.132, issue.3, pp.1104-1116, 2007. ,
DOI : 10.1053/j.gastro.2006.12.039
[Ca2+]i Reduction Increases Cellular Proliferation and Apoptosis in Vascular Smooth Muscle Cells: Relevance to the ADPKD Phenotype, Circulation Research, vol.96, issue.8, pp.873-880, 2005. ,
DOI : 10.1161/01.RES.0000163278.68142.8a
Altered pHi regulation and Na+/HCO3- transporter activity in choroid plexus of cilia-defective Tg737orpk mutant mouse, AJP: Cell Physiology, vol.292, issue.4, pp.1409-1416, 2007. ,
DOI : 10.1152/ajpcell.00408.2006
cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway11See Editorial by Grande, p. 1770, Kidney International, vol.57, issue.4, pp.1460-1471, 2000. ,
DOI : 10.1046/j.1523-1755.2000.00991.x
The Secretion of Fluid by Renal Cysts from Patients with Autosomal Dominant Polycystic Kidney Disease, New England Journal of Medicine, vol.329, issue.5, pp.310-313, 1993. ,
DOI : 10.1056/NEJM199307293290503
Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease, Nature Medicine, vol.10, issue.4, pp.363-364, 2004. ,
DOI : 10.1038/nm1004
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease, New England Journal of Medicine, vol.367, issue.25, pp.2407-2418, 2012. ,
DOI : 10.1056/NEJMoa1205511
Volume Progression in Polycystic Kidney Disease, New England Journal of Medicine, vol.354, issue.20 ,
DOI : 10.1056/NEJMoa054341
Apelin and copeptin: Two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease, Peptides, vol.49, pp.1-8, 2013. ,
DOI : 10.1016/j.peptides.2013.08.007
Increased Water Intake Decreases Progression of Polycystic Kidney Disease in the PCK Rat, Journal of the American Society of Nephrology, vol.17, issue.8, pp.2220-2227, 2006. ,
DOI : 10.1681/ASN.2006030251
Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population, American Journal of Hypertension, vol.17, issue.11, pp.1029-1034, 2004. ,
DOI : 10.1016/j.amjhyper.2004.06.020
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease, Kidney International, vol.41, issue.5, pp.1311-1319, 1992. ,
DOI : 10.1038/ki.1992.195
Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease, Nephrology Dialysis Transplantation, vol.27, issue.4 ,
DOI : 10.1093/ndt/gfr467
Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease, New England Journal of Medicine, vol.371, issue.24, pp.2267-2276, 2014. ,
DOI : 10.1056/NEJMoa1402686
Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease, New England Journal of Medicine, vol.371, issue.24, pp.2255-2266, 2014. ,
DOI : 10.1056/NEJMoa1402685
Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group ,
Type of PKD1 Mutation Influences Renal Outcome in ADPKD, Journal of the American Society of Nephrology, vol.24, issue.6, pp.1006-1013, 2013. ,
DOI : 10.1681/ASN.2012070650
Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease, J. Am. Soc. Nephrol ,
Extended Follow-Up of Unruptured Intracranial Aneurysms Detected by Presymptomatic Screening in Patients with Autosomal Dominant Polycystic Kidney Disease, Clinical Journal of the American Society of Nephrology, vol.6, issue.6, pp.1274-1285, 2011. ,
DOI : 10.2215/CJN.09731110
Screening for Intracranial Aneurysm in 355 Patients With Autosomal-Dominant Polycystic Kidney Disease, Stroke, vol.42, issue.1, pp.204-206, 2011. ,
DOI : 10.1161/STROKEAHA.110.578740
Association of mutation position in polycystic kidney disease 1 ,
Intracranial aneurysms in autosomal dominant polycystic kidney disease, Kidney International, vol.45, issue.4, pp.1140-1146, 1994. ,
DOI : 10.1038/ki.1994.151
Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease, J. Am. Soc. Nephrol. JASN, vol.3, pp.88-95, 1992. ,
Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment, The Lancet, vol.362, issue.9378, pp.103-110, 2003. ,
DOI : 10.1016/S0140-6736(03)13860-3
Vascular expression of polycystin, J. Am. Soc. Nephrol. JASN, vol.8, pp.616-626, 1997. ,
Polycystin: In vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein, Proceedings of the National Academy of Sciences, vol.94, issue.12 ,
DOI : 10.1073/pnas.94.12.6397
Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1, American Journal of Kidney Diseases, vol.38, issue.6, pp.1208-1216, 2001. ,
DOI : 10.1053/ajkd.2001.29216
Cardiovascular Abnormalities Associated with Adult Polycystic Kidney Disease, Annals of Internal Medicine, vol.100, issue.5, pp.683-688, 1984. ,
DOI : 10.7326/0003-4819-100-5-683
Estrogens and the pathophysiology of the biliary tree, World Journal of Gastroenterology, vol.12, issue.22 ,
DOI : 10.3748/wjg.v12.i22.3537
Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease ,
Hepatic venous outflow obstruction in autosomal dominant polycystic kidney disease, J. Am. Soc. Nephrol. JASN, vol.5, pp.1186-1192, 1994. ,
Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis, The Lancet Neurology, vol.10, issue.7, pp.626-636, 2011. ,
DOI : 10.1016/S1474-4422(11)70109-0
Incidental Findings on Brain MRI in the General Population, New England Journal of Medicine, vol.357, issue.18 ,
DOI : 10.1056/NEJMoa070972
The International Cooperative Studyon the Timing of Aneurysm Surgery, Journal of Neurosurgery, vol.73, issue.1, pp.18-36, 1990. ,
DOI : 10.3171/jns.1990.73.1.0018
Multiple Intracranial Aneurysms in a Defined Population, Neurosurgery, vol.35, issue.5, pp.803-808, 1994. ,
DOI : 10.1227/00006123-199411000-00001
Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening, The Lancet Neurology, vol.13, issue.4, pp.393-404, 2014. ,
DOI : 10.1016/S1474-4422(14)70015-8
Subarachnoid Hemorrhage: A Preventable Disease With a Heritable Component, Stroke, vol.33, issue.5, pp.1321-1326, 2002. ,
DOI : 10.1161/01.STR.0000014773.57733.3E
Risks and benefits of screening for intracranial aneurysms in firstdegree relatives of patients with sporadic subarachnoid hemorrhage, N. Engl. J. Med, vol.341, pp.1344-1350, 1999. ,
Familial intracranial aneurysms, The Lancet, vol.349, issue.9049, pp.380-384, 1997. ,
DOI : 10.1016/S0140-6736(97)80009-8
Genetic risk factors for intracranial aneurysms: A meta-analysis in more than 116,000 individuals, Neurology, vol.80, issue.23, pp.2154-2165, 2013. ,
DOI : 10.1212/WNL.0b013e318295d751
Characteristics of intracranial aneurysms and subarachnoid haemorrhage in patients with polycystic kidney disease, Journal of Neurology, vol.250, issue.4, pp.418-423, 2003. ,
DOI : 10.1007/s00415-003-0997-0
Small Unruptured Intracranial Aneurysm Verification Study: SUAVe Study, Japan, Stroke, vol.41, issue.9, pp.1969-1977, 2010. ,
DOI : 10.1161/STROKEAHA.110.585059
Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture, Journal of Neurosurgery, vol.108, issue.5, pp.379-387, 2000. ,
DOI : 10.3171/JNS/2008/108/5/1052
Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture, Journal of Neurosurgery, vol.108, issue.5, pp.1052-1060, 2008. ,
DOI : 10.3171/JNS/2008/108/5/1052
The natural course of unruptured cerebral aneurysms in a Japanese cohort, N. Engl. J. Med, vol.366, pp.2474-2482, 2012. ,
Rupture rate for patients with untreated unruptured intracranial aneurysms in South Korea during 2006???2009, Journal of Neurosurgery, vol.117, issue.1, pp.53-59, 2012. ,
DOI : 10.3171/2012.3.JNS111221
The unchanging pattern of subarachnoid hemorrhage in a community, Neurology, vol.30, issue.10, pp.1034-1040, 1980. ,
DOI : 10.1212/WNL.30.10.1034
Management of cerebral aneurysms in autosomal dominant polycystic kidney disease, J. Am. Soc. Nephrol. JASN, vol.13, pp.269-276, 2002. ,
The Epidemiology of Admissions of Nontraumatic Subarachnoid Hemorrhage in the United States, Neurosurgery, vol.73, issue.2, pp.217-222, 2013. ,
DOI : 10.1227/01.neu.0000430290.93304.33
Intracranial aneurysm screening: indications and advice for practice, The Lancet Neurology, vol.4, issue.2 ,
DOI : 10.1016/S1474-4422(05)00993-2
Evaluation of cerebral aneurysms with helical CT: correlation with conventional angiography and MR angiography., Radiology, vol.192, issue.3, pp.717-722, 1994. ,
DOI : 10.1148/radiology.192.3.8058939
Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?, Nephrology Dialysis Transplantation, vol.21, issue.4, pp.1104-1108, 2006. ,
DOI : 10.1093/ndt/gfk062
Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging, Journal of the American Society of Nephrology, vol.17, issue.9, pp.2359-2362, 2006. ,
DOI : 10.1681/ASN.2006060601
Incidence of Nephrogenic Systemic Fibrosis in Patients Undergoing Dialysis After Contrast-Enhanced Magnetic Resonance Imaging With Gadolinium-Based Contrast Agents, Investigative Radiology, vol.49, issue.2, pp.109-115, 2014. ,
DOI : 10.1097/RLI.0000000000000000
URL : https://hal.archives-ouvertes.fr/inserm-01102645
3.0-Tesla MR angiography of intracranial aneurysms: Comparison of time-of-flight and contrast-enhanced techniques, Journal of Magnetic Resonance Imaging, vol.216, issue.2, pp.97-102, 2005. ,
DOI : 10.1002/jmri.20247
URL : https://hal.archives-ouvertes.fr/hal-00461660
Improved image quality of intracranial aneurysms: 3.0-T versus 1.5-T time-of-flight MR angiography ,
Better Outcomes with Treatment by Coiling Relative to Clipping of Unruptured Intracranial Aneurysms in the United States, 2001-2008, American Journal of Neuroradiology, vol.32, issue.6, pp.1071-1075, 2001. ,
DOI : 10.3174/ajnr.A2453
Autosomal-dominant polycystic kidney disease ,
URL : https://hal.archives-ouvertes.fr/hal-01328055
Renal transplantation in autosomal dominant polycystic kidney disease, Nature Reviews Nephrology, vol.16, issue.8, pp.455-465, 2014. ,
DOI : 10.1038/nrneph.2014.104
Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: Contribution of extrarenal complications to mortality, American Journal of Kidney Diseases, vol.38, issue.4, pp.777-784, 2001. ,
DOI : 10.1053/ajkd.2001.27720
Risk of intracranial hemorrhage associated with autosomal dominant polycystic kidney disease in patients with end stage renal disease, BMC Nephrology, vol.7, issue.10, p.39, 2014. ,
DOI : 10.1016/j.semnephrol.2010.06.002
car il est inutile de l'inquiéter J'évoque tout de même systématiquement cette complication et la conduite à tenir en cas de signes évocateurs de rupture J'évoque cette complication au cas par cas, en fonction de la demande du patient Pour terminer ,